0
1. 10. 2009.
FP36-WE-04 Enkorten administration and its effects on gadolinium enhanced T1 and PD/T2 magnetic resonance imaging (MRI) lesions in patients suffering from relapsing-remitting multiple sclerosis (RRMS)